Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; Bleeding; Early hemorrhagic death; Coagulopathy;
مقالات ISI لوسمی پرومیلوسیتیک حاد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; Bone marrow; Case report; Fibrosis; Reticulin; Review;
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; APL early deaths; APL induction;
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; AML; AYA; HSCT; Low- to middle-income countries;
Keywords: لوسمی پرومیلوسیتیک حاد; VTE; venous thromboembolism; HSCT; hematopoietic stem cell transplant; LMWH; low molecular weight heparin; IMIDs; immunomodulatory drugs; AML; acute myeloid leukemia; IQR; interquartile range; TAT; thrombin antithrombin; FVII; factor VII; FVIII; factor VI
Keywords: لوسمی پرومیلوسیتیک حاد; ADP; adenosine diphosphate; ATP; adenosine triphosphate; APL; acute promyelocytic leukemia; Del-1; developmental endothelial locus-1; ECM; extracellular matrix; EGF; endothelial growth factor; EVs; extracellular vesicles; FA; fatty acid; LDL; low density
Keywords: لوسمی پرومیلوسیتیک حاد; 5-FU; 5-fluorouracil; AF; atrial fibrillation; ALK; anaplastic lymphoma kinase; APD; action potential duration; APL; acute promyelocytic leukemia; BCR-ABL; breakpoint cluster region-Abelson; BTK; Bruton tyrosine kinase; CD20; cluster of differentiation 20
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; Differentiation; Anti-CD44 mAb; All-trans retinoic acid; FICZ; Apoptosis; Synergy;
Keywords: لوسمی پرومیلوسیتیک حاد; AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; ADAM; a disintegrin and metalloproteinase enzymes; ALDH; aldehyde dehydrogenase; ABC; ATP - binding cassette; BWS; Beckwith-Wiedemann syndrome; BMP; bone morphogenetic proteins; CSC; cancer s
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; Relapse; Survival; Monitoring;
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; IC-APL protocol; Developing countries; Survival;
Keywords: لوسمی پرومیلوسیتیک حاد; acute promyelocytic leukemia; advantages; arsenic trioxide; shortcomings; side effects; therapeutics;
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; Arsenic trioxide; Prognostic factors; CD56 expression; FLT3 mutation;
Keywords: لوسمی پرومیلوسیتیک حاد; ABL; Abelson; ALL; acute lymphocytic leukemia; AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; BC; blast crisis; BCR; breakpoint cluster region; BMP; bone morphogenetic protein; CBP; CREB-binding protein; CDK; cyclin dependent kinase; CEBP
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; All-trans retinoic acid (ATRA); Arsenic trioxide (ATO); Coagulopathy; Early death; Differentiation syndrome;
Keywords: لوسمی پرومیلوسیتیک حاد; AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; ASX; additional sex combs; BM; bone marrow; bZIP; leucine zipper; C/EBPα; CCAAT/enhancer binding protein α; CN-AML; normal karyotype-AML; CR; complete remissions; DFS; disease-free survival
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; Additional cytogenetic abnormalities; Arsenic trioxide; Prognosis;
Keywords: لوسمی پرومیلوسیتیک حاد; CoCl2; cobalt chloride; AML; acute myeloid leukemia; HIF-1 α; hypoxia-inducible factor-1 α; CQ; chloroquine; LAMP1 and 2; lysosome-associated membrane proteins 1 and 2; APL; acute promyelocytic leukemia; ATRA; all-trans retinoic acid; ATO; arsenic triox
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; Bone morphogenetic proteins; All-trans retinoic acid; Differentiation; ID genes; Cell lines; Patients;
Keywords: لوسمی پرومیلوسیتیک حاد; GRIP1; glucocorticoid receptor-interacting protein 1; TIF2; translation initiation factor 2; SRC; steroid receptor coactivator; NR; nuclear receptor; AD; activation domain; CBP; CREB binding protein; APL; acute promyelocytic leukemia; RAR; retinoic acid r
Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; Arsenic trioxide; ATRA; Combination therapy;
Long noncoding RNAs act as regulators of autophagy in cancer
Keywords: لوسمی پرومیلوسیتیک حاد; lncRNA; long noncoding RNA; miRNA; microRNA; EMT; epithelial-mesenchymal transition; Atg; autophagy-related gene; HOTAIR; HOX antisense intergenic RNA; HCC; hepatocellular carcinoma; HULC; highly upregulated liver cancer; MALAT1; metastasis-associated lun
LncRNA HOXA-AS2 and its molecular mechanisms in human cancer
Keywords: لوسمی پرومیلوسیتیک حاد; lncRNA; HOXA-AS2; Diagnosis; Therapeutic target; Prognosis; APL; Acute promyelocytic leukemia; ATRA; All trans retinoic acid; Bax; BCL2-Associated X; BC; Breast cancer; Bcl-2; B-cell lymphoma-2; c-Myc; MYC proto-oncogene; CRC; Colorectal cancer; DDIT3; DN
PML nuclear bodies, membrane-less domains acting as ROS sensors?
Keywords: لوسمی پرومیلوسیتیک حاد; AKT; AKT serine/threonine kinase; AMPK; AMP activated protein kinase; AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; FOXO1; forkhead box O1; FAO; fatty acid oxidation; HIF1A; hypoxia inducible factor 1 alpha subunit; KEAP1; Kelch-like ery
Secondary clonal hematologic neoplasia following successful therapy for acute promyelocytic leukemia (APL): A report of two cases and review of the literature
Keywords: لوسمی پرومیلوسیتیک حاد; Acute myelocytic leukemia (AML); Secondary clone; Myelodysplastic syndrome (MDS); Therapy-related acute myelocytic leukemia (t-AML); Therapy-related myelodysplastic syndrome (t-MDS); AML; acute myelocytic leukemia; APL; acute promyelocytic leukemia; ATO;
Clinical characteristics of acute promyelocytic leukemia with the STAT5B-RARA fusion gene
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; STAT5B-RARA; Drug resistance; Gene fusion;
The functional roles of PML nuclear bodies in genome maintenance
Keywords: لوسمی پرومیلوسیتیک حاد; PML-NB; promyelocytic leukemia nuclear body; DSBs; DNA double-strand breaks; HR; homologous recombination; APL; acute promyelocytic leukemia; ALT; alternative lengthening of telomere; APB; ALT-associated PML bodies; PML nuclear body; SUMOylation; DNA repa
Arsenic speciation in hair and nails of acute promyelocytic leukemia (APL) patients undergoing arsenic trioxide treatment
Keywords: لوسمی پرومیلوسیتیک حاد; Arsenic speciation; Hair; Nails; Acute promyelocytic leukemia; Biomarker; Therapeutic;
Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer
Keywords: لوسمی پرومیلوسیتیک حاد; 5â²DFCR; 5â²deoxy-5-fluorocytidine; 5â²DFUR; 5â²-deoxy-5-fluorouridine; 5-FU; 5-fluorouracil; AEs; adverse events; AML; acute promyelocytic leukemia; AU; arbitrary unit; CDA; cytidine deaminase; CES; carboxylesterase; DPD; dihydropyrimidine dehydrogen
Antileukemic effect of paclitaxel in combination with metformin in HL-60 cell line
Keywords: لوسمی پرومیلوسیتیک حاد; APL; acute promyelocytic leukemia; AML; acute myeloid leukemia; PML/RARα; promyelocytic leukemia/retinoic acid receptor α; ATRA; all-trans retinoic acid; ATO; arsenic trioxide; T2DM; Type 2 Diabetes Mellitus; mTORC1; rapamycin complex 1; AMPK; AMP-activ
Different roles of Nrf2 and NFKB in the antioxidant imbalance produced by esculetin or quercetin on NB4 leukemia cells
Keywords: لوسمی پرومیلوسیتیک حاد; Antioxidants; Apoptosis; Esculetin; Hydrogen peroxide; Reactive oxygen species; Tert-butylhydroperoxide; APL; Acute promyelocytic leukemia; Annexin V-FITC; fluorescein isothiocyanate coupled to annexin V; BSO; buthionine-[SR]-sulfoximine; DMSO; dimethyl s
Novel combined Ato-C treatment synergistically suppresses proliferation of Bcr-Abl-positive leukemic cells in vitro and in vivo
Keywords: لوسمی پرومیلوسیتیک حاد; Arsenic trioxide; Cisplatin; Combination therapy; Bcr-Abl-positive leukemia; Apoptosis; APL; acute promyelocytic leukemia; ATO; arsenic trioxide; Ato-C; ATO/CDDP; CDDP; Cisplatin; CI; combination index; DRI; dose-reduction index; CML; Chronic myelogenous
Autophagy as a pharmacological target in hematopoiesis and hematological disorders
Keywords: لوسمی پرومیلوسیتیک حاد; 3-MA; 3-methyladenine; ALL; acute lymphoblastic leukemia; AMKL; acute megakaryoblastic leukemia; AML; acute myeloid leukemia; AMPK; 5â²-adenosine monophosphate-activated protein kinase; APL; acute promyelocytic leukemia; Atg; autophagy-related proteins;
Microgranular acute promyelocytic leukemia presenting with leukopenia and an unusual immunophenotype
Keywords: لوسمی پرومیلوسیتیک حاد; Microgranular APL; Hypogranular APL; Acute promyelocytic leukemia; APL; M3v; Leukopenia; Early death;
Nucleostemin silencing induces differentiation and potentiates all-trans-retinoic acid effects in human acute promyelocytic leukemia NB4 cells via autophagy
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; All-trans-retinoic acid; Autophagy; Differentiation; Nucleostemin;
In vitro studies on the role of recombinant human soluble thrombomodulin in the context of retinoic acid mediated APL differentiation syndrome
Keywords: لوسمی پرومیلوسیتیک حاد; Thrombomodulin; Acute promyelocytic leukemia; Differentiation syndrome; Coagulopathy;
Efficacy of recombinant factor VIIa for severe bleeding complicated by platelet transfusion refractoriness in patients with hematologic malignancies
Keywords: لوسمی پرومیلوسیتیک حاد; rFVIIa; recombinant factor VIIa; PTR; platelet transfusion refractoriness; CR; complete responses; PR; partial response; NR; no response; CCI; corrected count increment; PI; platelet count increment; BSA; body surface area; PD; the dose of platelets trans
An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy
Keywords: لوسمی پرومیلوسیتیک حاد; AA; Ascorbic acid; AEM1; ARE expression modulator 1; AEG1; Astrocyte elevated gene-1; Akt; Protein kinase B; AMPK; AMP-activated protein kinase; APL; Acute promyelocytic leukemia; ARE; Antioxidant response element; ATO; Arsenic trioxide; Bach; BTB and CNC
A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; Molecular risk factors; Prognosis; Relapse; Survival;
Correlation between FLT3-ITD status and clinical, cellular and molecular profiles in promyelocytic acute leukemias
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; t(15; 17); FLT3-ITD; PML-RARA; AML M3;
Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma
Keywords: لوسمی پرومیلوسیتیک حاد; HCC; hepatocellular carcinoma; ATO; arsenic trioxide; APL; acute promyelocytic leukemia; PML; promyelocytic leukemia protein; RARα; retinoic acid receptor α; ALDH3A1; aldehyde dehydrogenase 3 family member A1; qRT-PCR; quantitative real-time reverse tra
Induction of the autophagy-associated gene MAP1S via PU.1 supports APL differentiation
Keywords: لوسمی پرومیلوسیتیک حاد; MAP1S; PU.1; Autophagy; Acute promyelocytic leukemia; All-trans retinoic acid (ATRA); Neutrophil;
Dequalinium induces cytotoxicity in human leukemia NB4 cells by downregulation of Raf/MEK/ERK and PI3K/Akt signaling pathways and potentiation of specific inhibitors of these pathways
Keywords: لوسمی پرومیلوسیتیک حاد; APL; acute promyelocytic leukemia; ATO; arsenic trioxide; ATRA; all-trans retinoic acid; DQA; dequalinium; GSH; glutathione; NB4; human acute promyelocytic leukemia derived cell line; PML; promyelocytic leukemia; ROS; reactive oxygen species; Dequalinium;
Interaction of adenanthin with glutathione and thiol enzymes: Selectivity for thioredoxin reductase and inhibition of peroxiredoxin recycling
Keywords: لوسمی پرومیلوسیتیک حاد; APL; acute promyelocytic leukemia; DTNB; dithiobis-2-nitrobenzoic acid: DTPA, diethylenetriaminepentaacetic acid; NEM; N-ethylmaleimide; Prx; peroxiredoxin.; Peroxiredoxin; Electrophile; Thioredoxin reductase; Glutaredoxin; Adenanthin; Glutathione; Glutat
Retinoic acid induces adhesion and migration in NB4 cells through Pyk2 signaling
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; Extramedullary disease; ATRA; Pyk2; Adhesion; Migration;
Phosphorylation of serine 323 of ASB2α is pivotal for the targeting of filamin A to degradation
Keywords: لوسمی پرومیلوسیتیک حاد; AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; AR; ankyrin repeat; CID; collision-induced dissociation; CRL5; cullin5-RING E3 ubiquitin ligases; Erk; extracellular signal-regulated kinase; ETD; electron transfer dissociation; E3; E3 ubiqu
Microarray, gene sequencing, and reverse transcriptase-polymerase chain reaction analyses of a cryptic PML-RARA translocation
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; PML-RARA; cryptic; RT-PCR; microarray;
Therapy-related acute myeloid leukemia with favorable cytogenetics: Still favorable?
Keywords: لوسمی پرومیلوسیتیک حاد; Acute myeloid leukemia; Therapy-related; Favorable risk; Cytogenetics; Acute promyelocytic leukemia; Core binding factor;
Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; Recombinant human soluble thrombomodulin; All-trans retinoic acid; Disseminated intravascular coagulation;
Combination therapy with arsenic trioxide, all-trans retinoic acid, and chemotherapy in acute promyelocytic leukemia patients with various relapse risks
Keywords: لوسمی پرومیلوسیتیک حاد; Acute promyelocytic leukemia; Arsenic trioxide; All-trans retinoic acid; Chemotherapy;